BioSpace News Archive

As part of the U.S. Food and Drug Administration’s ongoing commitment to fight the Coronavirus Disease 2019 (COVID-19) pandemic, today the agency issued guidance for immediate implementation

Astellas Pharma US, (“Astellas”) and the Astellas Global Health Foundation are each expanding support for global and local communities fighting COVID-19 by providing up to $2 million of new financial assistance, in aggregate, to meet the urgent demand for resources to help patients, healthcare workers and first responders.

RegeneRx Biopharmaceuticals, Inc. announced the publication of a new scientific study demonstrating a mechanism of action of thymosin beta 4 on human corneal epithelial cell migration and the downstream signaling pathways.

Trinity Health said this week that even nurses in a COVID-19 unit could not have N95 masks

Kyowa Kirin, Inc., an affiliate of Kyowa Kirin Co., Ltd. a global specialty pharmaceutical company, named Gary Zieziula, MBA, a 40-year veteran of the pharmaceutical industry and current member of the company’s North America Board of Directors, as its President, North America, effective April 1.

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces the completion of its acquisition of the core assets of Icagen’s North Carolina operations

Centene Corporation issued a reminder that it will release its 2020 first quarter financial results at approximately 6 a.m. on Tuesday, April 28, 2020, and host a conference call afterwards at approximately 8:30 a.m. to review the results.

Zentalis Pharmaceuticals, Inc. announced the pricing of its initial public offering of 9,180,000 shares of common stock at a public offering price of $18.00 per share, for total gross proceeds of approximately $165.2 million, before deducting underwriting discounts and commissions and offering expenses payable by Zentalis.

ResMed has released the following statement regarding White House Memorandum on Order Under the Defense Production Act Regarding the Purchase of Ventilators: